Phase 2
Completed N=260
Comparing Smoking Treatment Programs for Lighter Smokers - 1
Source: ClinicalTrials.gov NCT00086411 ↗Enrolled (actual)
260
Serious AEs
0.8%
Results posted
Mar 2014
Primary outcomePrimary: Percent Treatment Sessions Attended — 77.9; 85.9; 66.8; 66.6 Percentage of attended tx. sessions — p=<0.017
Summary
The purpose of this study was to compare two different types of Food and Drug Administration (FDA) approved smoking cessation medications (nicotine patch or bupropion) used in conjunction with two levels of counseling. It was hypothesized that the higher level of counseling would have the highest rates of treatment completion and highest rates of abstinence.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percent Treatment Sessions Attended |
77.9; 85.9; 66.8; 66.6 | <0.017 sig |
| SECONDARY Delineate Mediators Associated With Different Treatment Conditions (i.e., Medication Compliance, Participant Views of Self-help Written Materials and Counseling Type. |
— | — |
Eligibility Criteria
Light smokers (6-15 cigarettes per day
Inclusion Criteria
Mentally and physically stable, non-pregnant, light smokers (6-15 cigarettes per day)
Exclusion Criteria
Please contact site for more information
Data sourced from ClinicalTrials.gov (NCT00086411). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.